Spermosens AB (9R5)
XFRA XFRA Primary XSTU Summary
Spermosens AB (9R5) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Spermosens AB ever had a stock split?
Spermosens AB Profile
| Professional Services Industry | Industrials Sector | Dr. Tore Duvold CEO | XFRA Exchange | SE0015346424 ISIN |
| SE Country | 4 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Spermosens AB is a pioneering company based in Lund, Sweden, dedicated to advancing the field of reproductive health through the research, development, and commercialization of cutting-edge diagnostic technologies. Founded in 2018, the company focuses on addressing the challenges of male infertility by offering innovative solutions for fertility diagnostics and treatments tailored to the in vitro fertilization (IVF) market. Through its groundbreaking work, Spermosens AB aims to enhance the effectiveness of fertility treatments and support individuals and couples on their journey to parenthood.
Products and Services
- JUNO-Checked
A forefront device innovated by Spermosens AB, JUNO-Checked stands out as a revolutionary tool in the field of fertility diagnostics. By precisely measuring the binding interaction between a sperm cell and an egg cell, this device facilitates a more informed and individualized approach to selecting fertility treatments. Tailored specifically for the IVF market, JUNO-Checked empowers healthcare providers to optimize treatment strategies based on concrete, measured parameters of sperm-egg interaction, thereby increasing the chances of successful fertilization and pregnancy.
